Sameer and his team
-
Role of GLP-1 receptor agonists in pediatric obesity: Benefits, risks, and approaches to patient selection
Diagnosis and management of IUGR, in Intrauterine Growth Restriction A Etiology and Management , eds KingdomJ.BakerP
Patients should seek urgent medical advice if they experience any of the following after taking any weight loss supplement or medicine: Call 999 immediately for severe chest pain, difficulty breathing, or signs of a serious allergic reaction (anaphylaxis) such as swelling of the face, lips, or throat Contact your GP or call NHS 111 for severe or persistent abdominal pain, palpitations, significant changes in mood or behaviour, or a skin rash The MHRA operates a Yellow Card reporting scheme for suspected adverse reactions to both medicines and supplements
Incretin-based drugs are now being investigated and in some cases approved for a wide range of conditions, including cardiovascular disease, neurodegenerative disorders, and even substance use disorder
